dihydroergotamine has been researched along with prazosin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batink, H; de Jonge, A; Thoolen, MJ; Timmermans, PB; van Zwieten, PA; Wilffert, B | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Müller-Schweinitzer, E | 1 |
| Kato, R; Nakadate, T; Nakaki, T | 1 |
| Morris, JL | 1 |
| Centurión, D; De Vries, P; Rabelo, G; Sánchez-López, A; Saxena, P; Villalón, CM | 1 |
| Johnson, ZB; Looper, ML; Rorie, RW; Rosenkrans, CF; Wang, H | 1 |
| Buonvicino, D; Chiarugi, A; De Cesaris, F; Muzzi, M | 1 |
1 review(s) available for dihydroergotamine and prazosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for dihydroergotamine and prazosin
| Article | Year |
|---|---|
Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Blood Pressure; Brain; Cell Membrane; Clonidine; Kinetics; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha; Structure-Activity Relationship; Vasoconstriction | 1984 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins.
Topics: Cocaine; Dihydroergotamine; Humans; In Vitro Techniques; Norepinephrine; Pizotyline; Prazosin; Receptors, Adrenergic, alpha; Receptors, Serotonin; Saphenous Vein; Vasoconstriction; Yohimbine | 1984 |
Alpha 2-adrenoceptors modulating insulin release from isolated pancreatic islets.
Topics: Animals; Dihydroergotamine; Epinephrine; In Vitro Techniques; Insulin; Islets of Langerhans; Male; Phenoxybenzamine; Phentolamine; Prazosin; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Yohimbine | 1980 |
Blockade of noradrenaline-induced constrictions by yohimbine and prazosin differs between consecutive segments of cutaneous arteries in guinea-pig ears.
Topics: Animals; Arteries; Dihydroergotamine; Ear, External; Female; Guinea Pigs; In Vitro Techniques; Ketanserin; Male; Muscle, Smooth, Vascular; Norepinephrine; Prazosin; Regional Blood Flow; Serotonin; Vasoconstriction; Yohimbine | 1994 |
Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Flow Velocity; Carotid Arteries; Clonidine; Dihydroergotamine; Dogs; Ergotamine; Female; Hemodynamics; Male; Methysergide; Oxadiazoles; Phenylephrine; Piperazines; Prazosin; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Serotonin Antagonists; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents; Yohimbine | 1999 |
Involvement of signaling pathways in bovine sperm motility, and effect of ergot alkaloids.
Topics: Animals; Cattle; Chelating Agents; Cholera Toxin; Cyclic AMP; Dihydroergotamine; Egtazic Acid; Ergot Alkaloids; Ergotamine; Male; Pertussis Toxin; Prazosin; Receptors, Adrenergic, alpha; Signal Transduction; Sperm Motility; Spermatozoa; Yohimbine | 2009 |
Acute and chronic triptan exposure neither alters rodent cerebral blood flow nor worsens ischemic brain injury.
Topics: Animals; Antihypertensive Agents; Brain Ischemia; Cerebral Cortex; Cerebrovascular Circulation; Dihydroergotamine; Disease Models, Animal; Drug Evaluation, Preclinical; Dura Mater; Male; Mice, Inbred C57BL; Prazosin; Pyrrolidines; Random Allocation; Rats, Sprague-Dawley; RNA, Messenger; Serotonin Receptor Agonists; Time Factors; Tryptamines; Vasoconstrictor Agents | 2017 |